[1]
L. Garcia-Marcos, “A very timely meta-analysis on Omalizumab in chronic spontaneous urticaria”, Allergol Immunopathol, vol. 47, no. 6, pp. 513–514, Dec. 2019, Accessed: Sep. 10, 2025. [Online]. Available: https://all-imm.com/index.php/aei/article/view/277